Last reviewed · How we verify
HCP1201, Fed followed by fasted — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
HCP1201, Fed followed by fasted (HCP1201, Fed followed by fasted) — Hanmi Pharmaceutical Company Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HCP1201, Fed followed by fasted TARGET | HCP1201, Fed followed by fasted | Hanmi Pharmaceutical Company Limited | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HCP1201, Fed followed by fasted CI watch — RSS
- HCP1201, Fed followed by fasted CI watch — Atom
- HCP1201, Fed followed by fasted CI watch — JSON
- HCP1201, Fed followed by fasted alone — RSS
Cite this brief
Drug Landscape (2026). HCP1201, Fed followed by fasted — Competitive Intelligence Brief. https://druglandscape.com/ci/hcp1201-fed-followed-by-fasted. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab